Welcome to our dedicated page for Olaplex Holdings SEC filings (Ticker: OLPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Olaplex Holdings, Inc. (NASDAQ: OLPX), a science-enabled, technology-driven beauty company focused on hair health and bond-building formulations. Through these filings, investors can review how Olaplex reports on its operations, financial condition and key risks as a manufacturer in the toilet preparation and broader health and beauty space.
Olaplex’s SEC submissions include annual reports on Form 10-K, which typically contain detailed discussions of its omnichannel business model spanning professional, specialty retail and direct-to-consumer channels, as well as risk factors such as competition in the beauty industry, brand perception, international operations and indebtedness. Quarterly reports on Form 10-Q provide interim financial statements and management’s discussion of recent performance, including net sales trends and the use of non-GAAP measures like adjusted EBITDA and adjusted gross profit, as described in the company’s earnings releases.
The company also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered quarterly results and the stock purchase agreement through which a subsidiary acquired Purvala Bioscience, a biotech company developing bioinspired technologies for health and beauty applications, as well as board appointments. For those monitoring insider activity, Form 4 filings (when available) report changes in beneficial ownership by directors, officers and other insiders.
On Stock Titan, these documents are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain lengthy sections of 10-K and 10-Q filings, highlight key items in 8-K disclosures, and make it easier to understand topics like non-GAAP reconciliations, risk factors and significant agreements. This allows users to quickly navigate Olaplex’s regulatory history, from its bond-focused haircare strategy to corporate transactions and governance developments, without reading every page of each filing.
Olaplex Holdings, Inc. has agreed to be acquired by Henkel in an all-cash merger. Henkel will pay $2.06 per share, valuing Olaplex at approximately $1.4 billion, a premium of about 55% to the prior closing price and 45% to the 30-day VWAP.
Merger Sub will merge into Olaplex, which will become a wholly owned Henkel subsidiary and be delisted from Nasdaq. Advent-affiliated funds holding roughly 75% of shares approved the deal by written consent. Closing is subject to antitrust and other regulatory clearances and customary conditions, with an outside date that can extend to September 30, 2027. A $40.44 million termination fee may be payable by Olaplex to Henkel in specified scenarios.
OLAPLEX HOLDINGS, INC. Chief People Officer Trisha L. Fox reported a sale of common stock tied to tax obligations. On this Form 4, she sold 25,421 shares at $1.26 per share in a “sell to cover” transaction required to satisfy tax withholding from vesting restricted stock units. After the transaction, she held 1,080,363 common shares directly.
OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported an open-market sale of 34,962 shares of common stock at $1.26 per share. According to the footnote, this was a required "sell to cover" transaction to satisfy tax withholding obligations on vesting restricted stock units. After the sale, Duffy directly held 982,855 shares, indicating he retained a substantial equity position in the company.
Olaplex Holdings, Inc. COO and CFO Catherine Dunleavy reported an open-market sale of 93,809 shares of common stock at $1.26 per share. According to the filing, the shares were sold solely to cover tax withholding obligations tied to the vesting of restricted stock units through a “sell to cover” transaction under the applicable RSU award agreement.
After this tax-related sale, Dunleavy directly holds 3,026,885 shares of Olaplex common stock. The transaction reflects a mechanistic step associated with equity compensation rather than a discretionary change in her investment position.
OLAPLEX HOLDINGS, INC. Chief Executive Officer Amanda Baldwin reported an open-market sale of 451,837 shares of common stock at $1.17 per share. According to the filing, this sale was required to cover tax withholding obligations tied to the vesting of restricted stock units through a “sell to cover” transaction.
After this tax-related sale, Baldwin directly holds 9,129,515 shares of common stock. Because the transaction was executed solely to satisfy tax obligations under the RSU award agreement, it reflects a routine administrative event rather than a discretionary change in investment exposure.
Morgan Stanley Smith Barney LLC Executive Services filed a Form 144 to sell Common stock. The filing lists 402,248 Common shares tied to Restricted Stock Units with an effective sale date of 03/11/2026, identified on NASDAQ for symbol OLPX. The record also shows a prior reported sale by Amanda Baldwin of 398,560 Common shares on 12/12/2025. The transactions are reported in a compensation context.
OLAPLEX HOLDINGS, INC. Chief People Officer Trisha L. Fox reported both a share sale and a large equity award. She sold 26,426 shares of Common Stock at $1.26 per share on March 9, 2026 to cover tax withholding obligations from vesting restricted stock units through a sell-to-cover transaction. On March 10, 2026, she was granted 384,615 RSUs under the 2021 Equity Incentive Plan, which vest in four equal annual installments from March 10, 2027 through March 10, 2030, subject to continued employment. Following these transactions, she directly holds 1,105,784 shares of Common Stock. The filing also notes an earlier transfer of 15,625 shares to her ex-spouse pursuant to a domestic relations order.
OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported both a stock sale and a new equity award. On March 9, 2026, he sold 34,824 shares of common stock at $1.26 per share in a sell-to-cover transaction to satisfy tax withholding obligations tied to vesting restricted stock units (RSUs).
On March 10, 2026, he received a new grant of 384,615 RSUs under the 2021 Equity Incentive Plan, with each unit representing one future share of common stock. These RSUs vest in four equal installments on March 10, 2027, 2028, 2029, and 2030, contingent on continued employment. After these transactions, he directly holds 1,017,817 shares of common stock.
DUNLEAVY CATHERINE reported acquisition or exercise transactions in this Form 4 filing.
OLAPLEX HOLDINGS, INC. reported that its COO and CFO, Catherine Dunleavy, received a grant of 1,153,846 shares of Common Stock in the form of restricted stock units under the company’s 2021 Equity Incentive Plan. After this award, she holds 3,120,694 shares directly.
The RSUs carry no purchase price and each unit represents the right to receive one share of common stock. They will vest in four equal installments on March 10 of 2027, 2028, 2029 and 2030, contingent on her continued employment with the company through each vesting date.